CGP-57148B useful for overcoming resistance to etoposide- and daunorubicin-induced apoptosis April 19, 1999
Good tolerance and in vivo proteasome inhibition demonstrated for multiple doses of PS-341 April 16, 1999
Two gene therapy approaches shown effective in treating hepatocellular carcinoma in rats April 16, 1999